Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
Within the last month, BrainStorm Cell Therapeutics Inc. announced the publication of pre-clinical data on the NurOwn system. NurOwn technology produces autologous, bone marrow-derived mesenchymal stem cells (MSCs) for…
 
								 
								 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
															 
            